Cookies show us what works. Privacy
Cookies show us what works. Privacy
29 funds hold it · Insiders net selling
Net selling: insiders sold $15.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 26, 2026
Financial period
Q3 2026
Earnings per share
$2.96 expected
Revenue
$5.46B expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 26, 2026 | $3.30est. $2.96 | +11.50%beat | $5.83Best. $5.46B+6.71% | +82.5%from $3.19B |
| Jun 30, 2026Reported Jul 27, 2026 | $2.54est. $2.31 | +10.04%beat | $4.70BCompany release | +62.4%from $2.89B |
| Mar 31, 2026Reported Apr 27, 2026 | $2.16est. $2.12 | +2.08%beat | $4.05BSEC filing | +52.8%from $2.65B |
| Dec 31, 2025Reported Jan 28, 2026 | $1.89est. $1.76 | +7.27%beat | $3.65BAlpha Vantage | +43.6%from $2.55B |
| Sep 30, 2025Reported Oct 27, 2025 | $2.28est. $1.38 | +65.22%beat | $3.19BSEC filing | +27.8%from $2.50B |
| Jun 30, 2025Reported Jul 28, 2025 | $1.82est. $1.23 | +47.97%beat | $2.89BSEC filing | +21.0%from $2.39B |
| Mar 31, 2025Reported Apr 24, 2025 | $0.74est. $1.12 | -33.93%miss | $2.65BSEC filing | +19.9%from $2.21B |
| Dec 31, 2024Reported Jan 29, 2025 | $1.29est. $0.90 | +43.33%beat | $2.55BAlpha Vantage | +18.9%from $2.14B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.65B | $4.05B | $4.70B | $5.83B |
| Cost of what it sold | $3.22B | $3.61B | $4.12B | $5.19B |
| Gross profit | $433.1M | $437.2M | $577.5M | $640.8M |
| What it spent | ||||
| Research and development | $30.2M | $41.2M | $46.3M | $51.2M |
| Sales and admin | $70.1M | $117.4M | $58.1M | $118.2M |
| Other operating costs | $12.0M | $6.5M | $14.8M | $11.4M |
| Total operating expenses | $112.3M | $165.1M | $119.2M | $180.8M |
| What was left | ||||
| Operating profit | $320.8M | $272.1M | $458.3M | $460.0M |
| Interest on debt | $12.8M | $16.0M | $21.2M | $24.1M |
| Profit before tax | $301.3M | $256.3M | $441.6M | $455.8M |
| Tax | $33.8M | $44.0M | $72.8M | $58.6M |
| Net profit | $267.5M | $212.3M | $368.8M | $397.2M |
| EBITDA | $366.6M | $311.9M | $506.8M | $528.4M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
36 macro signals shaping CLS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results